How have NVLNF shares performed in 2024?

Novelion Therapeutics' stock was trading at $0.7020 at the start of the year. Since then, NVLNF shares have increased by 0.0% and is now trading at $0.7020. View the best growth stocks for 2024 here .

How do I buy shares of Novelion Therapeutics?

Shares of NVLNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NVLNF

Novelion Therapeutics (NVLNF) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free NVLNF Stock Alerts

$0.70

-0.01 (-1.20%)

(As of 01/16/2020)

Compare

Today's Range: $0.70
▼
$0.75
50-Day Range: $0.70
▼
$0.70
52-Week Range: $0.51
▼
$1.00

Volume: 26,900 shs
Average Volume: 261,364 shs
Market Capitalization: $13.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Novelion Therapeutics alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Novelion Therapeutics

Novelion Therapeutics Inc., a biopharmaceutical company, develops therapies for individuals living with rare diseases in the United States, Japan, Brazil, and internationally. Its commercial products include metreleptin, a recombinant analog of human leptin, which is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy under the MYALEPTA brand name; and lomitapide capsule for the treatment of adult patients with homozygous familial hypercholesterolemia under the JUXTAPID and LOJUXTA brands. The company was formerly known as QLT Inc. and changed its name to Novelion Therapeutics Inc. in November 2016. Novelion Therapeutics Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

NVLNF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NVLNF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive NVLNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novelion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:NVLNF
CUSIP: N/A
CIK: N/A
Web: www.novelion.com
Phone: 617-500-7867
Fax: N/A
Employees: 109
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $130.43 million
Price / Sales: 0.11
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($4.69) per share
Price / Book: -0.15

Miscellaneous

Outstanding Shares: 19,619,000
Free Float: N/A
Market Cap: $13.77 million
Optionable: Not Optionable
Beta: 2.15

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Benjamin S. Harshbarger (Age 50)
Interim CEO, Gen. Counsel & Corp. Sec.
Mr. Michael D. Price (Age 61)
Exec. VP, CFO & Director
Ms. Barbara Y. Chan (Age 55)
VP & Chief Accounting Officer
Ms. Amanda Murphy
Director of Investor Relations & Corp. Communications
Ms. Linda Buono (Age 53)
Sr. VP of HR

Key Competitors

View All Competitors

NVLNF Stock Analysis - Frequently Asked Questions

How have NVLNF shares performed in 2024?: Novelion Therapeutics' stock was trading at $0.7020 at the start of the year. Since then, NVLNF shares have increased by 0.0% and is now trading at $0.7020.
View the best growth stocks for 2024 here.
How do I buy shares of Novelion Therapeutics?: Shares of NVLNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NVLNF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial